Nuffield Division of Clinical Laboratory Sciences
Head of Division
About NDCLS
Our aim is to study the pathology of human disease from the molecular to systems level, and to translate our findings into treatments for human disorders.
Read moreLatest Publications
Phenotypic and molecular characterization of a serum-free miniature erythroid differentiation system suitable for high-throughput screening and single-cell assays.
Mettananda S. et al, (2018), Exp Hematol, 60, 10 - 20
Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo.
Williams RM. et al, (2018), Development, 145
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S. et al, (2017), Nat Commun, 8
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.
Amatangelo MD. et al, (2017), Blood, 130, 732 - 741
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Stein EM. et al, (2017), Blood, 130, 722 - 731
The Latest News
Professor David Roberts elected Fellow of Academy of Medical Sciences
13 May 2022
David Roberts, Professor of Haematology at the Radcliffe Department of Medicine and Consultant Haematologist, has been elected a Fellow of the Academy of Medical Sciences
Congratulations to our new PIs!
31 March 2022
CRUK funding success for Ross Chapman and Sarah Gooding
17 March 2022
Spin-out company Alethiomics launches
15 December 2021
The enterprise will focus on developing targeted therapies for a specific family of blood cancers.